ElectroCore (Nasdaq:ECOR) announced that it agreed to acquire NeuroMetrix (Nasdaq:NURO) and its Quell neuromodulation platform. NeuroMetrix develops the Quell platform, a wearable, app- and cloud-enabled neuromodulation platform. It treats fibromyalgia symptoms and lower-extremity chronic pain. The company also offers DPNCheck, a point-of-care screening test for peripheral neuropathy. However, ElectroCore said it expects NeuroMetrix to divest […]
Mergers & Acquisitions
Teleflex reportedly in talks to buy Biotronik stent business
Teleflex could agree as soon as this month to acquire Biotronik’s vascular intervention unit. That’s according to a Dec. 4 Bloomberg report that cited people familiar with the matter, who said Teleflex was offering €500 million to €1 billion for the stent business. In a report out today, Needham & Co. Senior Research Analyst Mike […]
Bausch + Lomb is exploring a potential sale
Bausch + Lomb announced today that, in response to a request from regulatory authorities, it authorized the exploration of a potential sale. The Vaughan, Ontario-based eye care company received a request from the Canadian Investment Regulatory Organization (CIRO). It was related to stock volatility and market rumors. Bausch + Lomb stock trades on the New […]
Bausch + Lomb acquires glaucoma treatment company Elios Vision
Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery (MIGS) procedure. The Elios procedure uses an excimer laser to treat glaucoma in conjunction with cataract surgery without implants. Bausch + Lomb believes the deal enhances its glaucoma portfolio which already features pharmaceutical and surgical approaches. Compared […]
The top medtech stories of 2024
AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech stories. Meanwhile, medical device companies have been seeking more tuck-in M&A — and continuing to refocus and boost operational efficiency — to better prepare for whatever the future brings. Here are the top medtech stories that caught the attention […]
Siemens Healthineers acquires Novartis molecular imaging business
Siemens Healthineers announced today that it completed the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis. The newly acquired unit is a European manufacturing and distribution network of diagnostic radiopharmaceuticals for positron emission tomography (PET) scans. According to a news release, it will be known as “Advanced Accelerator Applications, a Siemens Healthineers company.” Reports first […]
Medtech M&A could be on the rise in 2025
Analysts from Bank of America predict a favorable environment for mergers and acquisitions in the medtech space in 2025. Travis Steed, Stephanie Piazzola, Craig Bijou and Enjia Cao say 2024 was “a typical year” in terms of M&A in medtech. They tracked 19 acquisitions of note with around $25 billion in disclosed deal price. Some […]
Haemonetics sells off whole blood assets for $67.1M
Haemonetics (NYSE:HAE) announced today that it agreed to sell its whole blood assets to GVS S.p.A for $67.1 million. GVS, a manufacturer of filter solutions for healthcare and life sciences, agreed to pay $44.6 million up front. The deal also includes up to $22.5 million in contingent earn-outs over the next four years. Under the […]
GE HealthCare to fully own Nihon Medi-Physics
GE HealthCare (Nasdaq:GEHC) announced today that it will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese radiopharmaceutical company. The purchase from Sumitomo Chemical is expected to close in early 2025, subject to regulatory approvals. Financial terms of the deal were not disclosed. GE HealthCare has already owned a […]
Medtronic acquires articulating instrument maker Fortimedix Surgical
Fortimedix Surgical announced today that it has been acquired by medtech giant Medtronic (NYSE:MDT). “We are pleased to share that Fortimedix Surgical was acquired by Medtronic,” the company wrote on LinkedIn. “A unique opportunity to leverage our articulating instrument technology for application across patient therapies. We look forward to joining Medtronic.” Fortimedix develops proprietary articulating […]
Henry Schein to acquire home care medical product supplier Acentus
Henry Schein today announced it signed an agreement to acquire Acentus, a national supplier of home care medical products. The Acentus transaction follows Henry Schein’s acquisition of Shield Healthcare in 2023 and Prism Medical Products in 2021. Financial terms of the latest deal were not disclosed. “As the delivery of health care in the U.S. […]
